
A placebo-controlled trial of hydroxychloroquine in patients hospitalized with COVID-19 finds the drug shortened time to recovery, possibly lessened severity.

A placebo-controlled trial of hydroxychloroquine in patients hospitalized with COVID-19 finds the drug shortened time to recovery, possibly lessened severity.

By giving patients plasma or serum from patients who have developed antibodies to a particular virus or bacteria, an infected patient is given a massive boost to their adaptive immune system, which confers passive immunity.

Here is a look at infectious disease-related FDA news from the week of March 29, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Check out the latest coronavirus news from April 3, 2020.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Rural counties are less likely to have an experienced HIV clinician, despite increasing HIV incidence.

As communities around the world race to treat patients with COVID-19, a new problem is emerging: how to deal with the rise in fatalities.

The coronavirus pandemic is disrupting clinical trials for multiple diseases, from Alzheimer's to Zika.

Check out the latest coronavirus news from April 2, 2020.

A report from the CDC’s COVID-19 Response Team includes preliminary data on patients with the highest risk of severe infection.

The authors of the analysis broke down palliative care during a pandemic into 8 critical categories.

Learn what Cidara Therapeutics has in development in this episode of Contagion® Connect.

In mouse models, the vaccine produced antibodies for SARS-CoV-2 which may offer sufficient protection.

Listen for a daily COVID-19 update.

Investigators recommend extending quarantine periods for recovering COVID-19 patients by an additional 2 weeks.

The virtual MJH Life Sciences Sleeves Up Blood Drive is being held from March 31 through April 30.

In a new editorial a team of engineers and computer scientists argue that the current pandemic moment ought to serve as a wake-up call for society and the public health community to embrace the opportunities of robotics.

A new commentary argues that the gradual pace at which we research other health challenges is not appropriate for a global pandemic.

Investigators look to answer questions about breast milk’s protective effects for infants from COVID-19, the infection caused by the novel coronavirus.

The goal of the program will be to quickly bring effective medical countermeasures to patients while also supporting research to assess the safety and efficacy of these therapies.

Listen for a daily COVID-19 update.

As March comes to an end, we look back at an unprecedented month in infectious disease news.

New guidelines on COVID-19 from WHO, CDC, and CMS advise long-term care facilities on protecting their elderly, vulnerable populations and staff.

A poster presented at CROI 2020 examined rates of TB screening among people living with HIV in PEPFAR supported countries.

After the MODIFY trial, investigators wanted to explore how bezlotoxumab treated patients in the real world.

Babies at risk for coronavirus due to maternal COVID-19 pneumonia showed favorable outcomes.

Health officials are calling for more intensive efforts to find, cure and prevent tuberculosis amid reports of slight declines in cases and deaths that are insufficient to meet global goals.

Stay up to date with our daily COVID-19 update.